Inhibitor Therapeutics (INTI) Non-Current Assets (2015 - 2026)
Inhibitor Therapeutics' (INTI) quarterly Non-Current Assets came in at $57410.0 in Q1 2026, down 31.87% YoY from $84268.0 in Q1 2025, and down 10.73% on a QoQ basis from $64307.0 in Q4 2025.
Inhibitor Therapeutics (INTI) Non-Current Assets (2015 - 2026) Analysis & Trends
Inhibitor Therapeutics (INTI) has 9 years of Non-Current Assets data on file, last reported at $57410.0 in Q1 2026.
- Quarterly Non-Current Assets fell 31.87% year-over-year to $57410.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $270532.0 (up 221.04% YoY) and the FY2025 annual result came in at $64307.0, changed N/A from the prior year.
- Non-Current Assets slipped to $57410.0 in Q1 2026, from $64307.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $84268.0 in Q1 2025 to a low of $57410.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | Inhibitor Therapeutics | 15.64 Mn | 15.64 Mn | - | 50,384.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,410.00 |
| Dec 31, 2025 | 64,307.00 |
| Sep 30, 2025 | 71,081.00 |
| Jun 30, 2025 | 77,734.00 |
| Mar 31, 2025 | 84,268.00 |
| Sep 30, 2021 | 2,439.00 |
| Jun 30, 2021 | 9,762.00 |
| Mar 31, 2021 | 17,085.00 |
| Dec 31, 2020 | 24,408.00 |
| Sep 30, 2020 | 31,731.00 |
| Jun 30, 2020 | 39,054.00 |
| Mar 31, 2020 | 46,377.00 |
| Dec 31, 2019 | 53,700.00 |
| Sep 30, 2019 | 61,023.00 |
| Jun 30, 2019 | 68,346.00 |
| Mar 31, 2019 | 75,669.00 |
| Dec 31, 2018 | 82,992.00 |
| Sep 30, 2018 | 90,315.00 |
| Jun 30, 2018 | 97,638.00 |
| Mar 31, 2018 | 104,961.00 |